Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
Nelson Leung, Angela Dispenzieri, Fernando C. Fervenza, Dragan Jevremovic, Robert A. Kyle, Vincent S. Rajkumar, Sanjeev Sethi & Samih H. Nasr
Department of Nephrology, Centre Hospitalier Universitaire et Université de Poitiers, Poitiers, France; CNRS UMR7276, Limoges, France; and Centre de Référence Amylose AL et Autres Maladies par Dépôt d’Immunoglobulines Monoclonales, Poitiers, France
Frank Bridoux
Veterans Administration Medical Center, New Orleans, LA, USA and Tulane University Medical School, Tulane, LA, USA
Vecihi Batuman
Centre for Haematology, Department of Medicine, Imperial College London and Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Aristeidis Chaidos
Department of Nephrology, Renal Medicine — University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK
Paul Cockwell
Department of Pathology, Renal Pathology Laboratory, Columbia University, College of Physicians and Surgeons, New York, NY, USA
Vivette D. D’Agati & Glen S. Markowitz
Department of Haematology and Immunology, University Hospital St Louis, Paris, France
Jean- Paul Fermand
The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash Univerity Easter Health Clinical School, Melbourne, Victoria, Australia
Simon Gibbs
National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London, UK
Julian D. Gillmore, Helen J. Lachmann & Ashutosh D. Wechalekar
Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA
Guillermo A. Herrera
Service d’Hématologie et de Thérapie Cellulaire, Centre de Référence des Amyloses Primitives et des Autres Maladies par Dépôts d’Immunoglobuline, CHU Limoges, Limoges, France
Arnaud Jaccard
Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Alexandra Hospital, Athens, Greece
Efstathios Kastritis
University Health Network, Princess Margaret Cancer Centre, Toronto, Canada
Vishal Kukreti
Arkana Laboratories, Little Rock, AR, USA
Christopher P. Larsen
Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria
Heinz Ludwig
Amyloidosis Research and Treatment Center, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
Giampaolo Merlini
Haematology Department, Princess Alexandra Hospital and School of Medicine, University of Queensland, Brisbane, Australia
Peter Mollee
Department of Pathology, Loyola University Medical Center, Maywood, IL, USA
Maria M. Picken
Department of Pathology, Hôpital Maisonneuve- Rosemont, Université de Montreal, Montreal, Quebec, Canada
Virginie Royal
Department of Medicine, University of Alabama at Birmingham and Department of Veterans Affairs Medical Center, Birmingham, AL, USA
Paul W. Sanders
Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
Christopher P. Venner
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium System, Charlotte, NC, USA
Peter M. Voorhees
Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
Brendan M. Weiss
